» Articles » PMID: 22378790

ATP Binding Site Mutagenesis Reveals Different Subunit Stoichiometry of Functional P2X2/3 and P2X2/6 Receptors

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 Mar 2
PMID 22378790
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present experiments was to clarify the subunit stoichiometry of P2X2/3 and P2X2/6 receptors, where the same subunit (P2X2) forms a receptor with two different partners (P2X3 or P2X6). For this purpose, four non-functional Ala mutants of the P2X2, P2X3, and P2X6 subunits were generated by replacing single, homologous amino acids particularly important for agonist binding. Co-expression of these mutants in HEK293 cells to yield the P2X2 WT/P2X3 mutant or P2X2 mutant/P2X3 WT receptors resulted in a selective blockade of agonist responses in the former combination only. In contrast, of the P2X2 WT/P2X6 mutant and P2X2 mutant/P2X6 WT receptors, only the latter combination failed to respond to agonists. The effects of α,β-methylene-ATP and 2-methylthio-ATP were determined by measuring transmembrane currents by the patch clamp technique and intracellular Ca(2+) transients by the Ca(2+)-imaging method. Protein labeling, purification, and PAGE confirmed the assembly and surface trafficking of the investigated WT and WT/mutant combinations in Xenopus laevis oocytes. In conclusion, both electrophysiological and biochemical investigations uniformly indicate that one subunit of P2X2 and two subunits of P2X3 form P2X2/3 heteromeric receptors, whereas two subunits of P2X2 and one subunit of P2X6 constitute P2X2/6 receptors. Further, it was shown that already two binding sites of the three possible ones are sufficient to allow these receptors to react with their agonists.

Citing Articles

Migraine signaling pathways: purine metabolites that regulate migraine and predispose migraineurs to headache.

Biringer R Mol Cell Biochem. 2023; 478(12):2813-2848.

PMID: 36947357 DOI: 10.1007/s11010-023-04701-7.


Established Protocols for cRNA Expression and Voltage-Clamp Characterization of the P2X7 Receptor in Xenopus laevis Oocytes.

Schmalzing G, Markwardt F Methods Mol Biol. 2022; 2510:157-192.

PMID: 35776325 DOI: 10.1007/978-1-0716-2384-8_9.


Enlightening activation gating in P2X receptors.

Sattler C, Benndorf K Purinergic Signal. 2022; 18(2):177-191.

PMID: 35188598 PMC: 9123132. DOI: 10.1007/s11302-022-09850-w.


Functional Coupling of Slack Channels and P2X3 Receptors Contributes to Neuropathic Pain Processing.

Lu R, Metzner K, Zhou F, Flauaus C, Balzulat A, Engel P Int J Mol Sci. 2021; 22(1).

PMID: 33401689 PMC: 7795269. DOI: 10.3390/ijms22010405.


Unravelling the intricate cooperativity of subunit gating in P2X2 ion channels.

Sattler C, Eick T, Hummert S, Schulz E, Schmauder R, Schweinitz A Sci Rep. 2020; 10(1):21751.

PMID: 33303878 PMC: 7729398. DOI: 10.1038/s41598-020-78672-w.


References
1.
Browne L, Jiang L, North R . New structure enlivens interest in P2X receptors. Trends Pharmacol Sci. 2010; 31(5):229-37. PMC: 2954318. DOI: 10.1016/j.tips.2010.02.004. View

2.
Khakh B, Burnstock G, Kennedy C, King B, North R, Seguela P . International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev. 2001; 53(1):107-18. View

3.
Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

4.
Gerevich Z, Zadori Z, Muller C, Wirkner K, Schroder W, Rubini P . Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization. Br J Pharmacol. 2007; 151(2):226-36. PMC: 2013946. DOI: 10.1038/sj.bjp.0707217. View

5.
Nicke A, Kerschensteiner D, Soto F . Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits. J Neurochem. 2005; 92(4):925-33. DOI: 10.1111/j.1471-4159.2004.02939.x. View